C12Y 106/03
Oxidoreductases acting on nadh or nadph: with oxygen as acceptor
Official title: with oxygen as acceptor (1.6.3)
C12Y106/03 (Oxidoreductases acting on nadh or nadph: with oxygen as acceptor) appears on 42 US grants and 79 published applications in this corpus.
Search patents in C12Y- Granted patents
- 42
- Published applications
- 79
- Assignees
- 48
- Inventors
- 157
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 0 | 2 |
| 2015 | 1 | 3 |
| 2016 | 3 | 4 |
| 2017 | 1 | 9 |
| 2018 | 3 | 3 |
| 2019 | 4 | 9 |
| 2020 | 6 | 4 |
| 2021 | 7 | 9 |
| 2022 | 4 | 9 |
| 2023 | 3 | 4 |
| 2024 | 7 | 8 |
| 2025 | 1 | 5 |
| 2026 | 2 | 7 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Heterologous proteins with axonemal proteins7 Jul 2026US 12,673,977 B2The Regents of the University of California
- Compositions and methods for treating amyotrophic lateral sclerosis2 Jun 2026US 12,644,122 B2Children's Medical Center Corporation
- Recombinant host cells and methods for the production of glyceric acid and downstream products7 Jan 2025US 12,188,008 B2Lygos, Inc.
- Plant cells and plants modified to increase resistance to necrotrophs or drought and methods of selecting and using the same10 Dec 2024US 12,163,143 B2Wisconsin Alumni Research Foundation
- Compositions and methods to regulate Renalase in the treatment of cancer26 Nov 2024US 12,152,085 B2Yale University
- Plants comprising bromoform production genes8 Oct 2026US 2026/0308605 A1Imi Tami Institute for Research and Development Ltd.
- Method for producing d-talitol, d-tagatose, and d-psicose8 Oct 2026US 2026/0308649 A1Annikki GmbH
- Oxidase-based chemiluminescence assay of phagocytic leukocytes in whole blood and body fluids applicable to point-of-care (poc) diagnostic testing point-of-care (poc) measurement of absolute neutrophil function (anf)27 Aug 2026US 2026/0251635 A1Binary, LLC
- Compositions, devices and methods for the control in vitro of chemical microambient in cell cultures6 Aug 2026US 2026/0226408 A1Alma Mater Studiorum - Università di Bologna
- Oxidase-based chemiluminescence assay of phagocytic leukocytes in whole blood and body fluids applicable to point-of-care (poc) diagnostic testing point-of-care (poc) measurement of absolute neutrophil function (anf)14 May 2026US 2026/0133184 A1Binary, LLC
Most cited
By later US patents
- Inhibition of oxidative stress in atrial fibrillation3US 9,932,588 B2Northwestern University · 2018
- Diagnosis and therapy of multiple sclerosis2US 10,633,427 B2Prindex S.R.L. · 2020
- Compositions for treatment of vascular disease2US 11,091,524 B1Houston Gene Therapeutics LLC · 2021
- Nucleic acid aptamers2US 9,139,835 B2University of Iowa Research Foundation · 2015
- Compositions to regulate renalase in the treatment of diseases and disorders1US 10,273,311 B2Yale University · 2019